1
|
Colditz G and Chia KS: Invasive breast
carcinoma: Introduction and general features. In: World Health
Organization, Pathology & Genetics. Tumours of the Breast.
Lakhani SR, Ellis IO, Schnitt ST, Tan PH and van de Vijver MC
(eds). IARC Press, Lyon, pp14-31, 2012.
|
2
|
Adami HO, Signorello LB and Trichopulos D:
Towards an understanding of breast cancer etiology. Semin Cancer
Biol. 8:225–262. 1998.PubMed/NCBI View Article : Google Scholar
|
3
|
Freedman LS, Kipnis V, Schatzkin A and
Potischman N: Methods of epidemiology: Evaluating the fat-breast
cancer hypothesis-comparing dietary instruments and other
developments. Cancer. 14:69–74. 2002.
|
4
|
Senzaki H, Tsubura A and Takada H: Effect
of eicosapentaenoic acid on the suppression of growth and
metastasis of human breast cancer cells in vivo and in vitro. World
Rev Nutr Diet. 88:117–125. 2001.PubMed/NCBI View Article : Google Scholar
|
5
|
Yamamoto D, Kiyozuka Y, Adachi Y, Takada
H, Hiroki K and Tsubura A: Synergistic action of apoptosis induced
by eicosapentaenoic acid and TNP-470 on human breast cancer cells.
Breast Cancer Res Treat. 55:149–169. 1999.PubMed/NCBI View Article : Google Scholar
|
6
|
VanderSluis L, Mazurak VC, Damaraju S and
Field CJ: Determination of relative efficacy of eicosapentaenoic
acid and docosahexaenoic acid for anti-cancer effects in human
breast cancer models. Int J Mol Sci. 18(2607)2017.PubMed/NCBI View Article : Google Scholar
|
7
|
Senzaki H, Iwamoto S, Ogura E, Kiyozuka Y,
Arita S, Kurebayashi J, Takada H, Hiroki K and Tubura A: Dietary
effects of fatty acids on growth and metastasis of KPL-1 human
breast cancer cells in vivo and in vitro. Anticancer Res.
18:1621–1627. 1998.PubMed/NCBI
|
8
|
Chung NW, Wu CT, Chen DR, Yeh CY and Lin
C: Hight levels of arachidonic acid and peroxisome
proliferator-activated receptor-alpha in breast cancer tissues and
associated with promoting cancer cell proliferation. J Nutr
Biochem. 24:274–281. 2013.PubMed/NCBI View Article : Google Scholar
|
9
|
Mead JF and Slaton WH Jr: Metabolism of
essential fatty acids. III. Isolation of 5,8,11-eicosatrienoic acid
from fat-deficient rats. J Biol Chem. 219:705–709. 1956.PubMed/NCBI
|
10
|
Fulco AJ and Mead JF: Metabolism of
essential fatty acids VIII. Origin of 5,8,11-eicosatrienoic acid in
the fat-deficient rat. J Biol Chem. 234:1411–1416. 1959.PubMed/NCBI
|
11
|
Ichi I, Kono N, Arita Y, Haga S, Arisawa
K, Yamano M, Nagase M, Fujiwara Y and Arai H: Identification of
genes and pathways involved in the synthesis of Mead acid (20:3
n-9), an indicator of essential fatty acid deficiency. Biochim
Biophys Acta. 1841:204–213. 2014.PubMed/NCBI View Article : Google Scholar
|
12
|
Kinoshita Y, Yoshizawa K, Hamazaki K,
Emoto Y, Yuri T, Yuki M, Shikata N, Kawashima H and Tsubura A: Mead
acid inhibits the growth of KPL-1 human breast cancer cells in
vitro and in vivo. Oncol Rep. 32:1385–1394.
2014.PubMed/NCBI View Article : Google Scholar
|
13
|
Kinoshita Y, Yoshizawa K, Hamazaki K,
Emoto Y, Yuri T, Yuki M, Kawashima H, Shikata N and Tsubura A:
Dietary effects of mead acid on
N-methyl-N-nitrosourea-induced mammary cancers in
female Sprague-Dawly rats. Biomed Rep. 4:33–39. 2016.PubMed/NCBI View Article : Google Scholar
|
14
|
Heyd VL and Eynard AR: Effects of
eicosatrienoic acid (20:3 n-9, Mead's acid) on some
premalignant-related properties of three human cancer cell lines.
Prostaglandins Other Lipid Mediat. 71:177–188. 2003.PubMed/NCBI View Article : Google Scholar
|
15
|
Tsubura A, Izuno Y, Shoji T, Kusunose N
and Morii S: Influence of strain and sex on the local development
of mammary tumors induced by direct application of DMBA powder to
rat mammary glands. Acta Pathol Jpn. 40:9–13. 1990.PubMed/NCBI View Article : Google Scholar
|
16
|
Sakuradani E, Kameda N, Hirano Y,
Nishihara M, Kawsashima H, Akimoto K, Higashiyama K, Ogawa J and
Shimizu S: Production of 5,8,11-eicosatrienoic acid by a delta5 and
delta6 desaturation activity-enhanced mutant derived from a delta12
desaturation activity-defective mutant of Mortierella alpine 1S-4.
Appl Microbiol Biotecnol. 60:281–287. 2002.PubMed/NCBI View Article : Google Scholar
|
17
|
Kawamura I, Mizota T, Kondo N, Shimomura K
and Kohsaka M: Antitumor effects of droloxifene, a new antiestrogen
drug, against 7,12-dimethylbenz (a) anthracence-induced mammary
tumor in rats. Japan J Pharmacol. 57:215–224. 1991.PubMed/NCBI View Article : Google Scholar
|
18
|
Kanematsu S, Yoshida K, Uehara N, Miki H,
Sasaki T, Kuro M, Lai YC, Kimura A, Yuri T and Tsubura A:
Sulforaphane inhibits the growth of KPL-1 human breast cancer cells
in vitro and suppress the growth and metastasis of
orthotopically transplanted KPL-1 cells in female athymic mice.
Oncol Rep. 26:603–608. 2011.PubMed/NCBI View Article : Google Scholar
|
19
|
Rodon CE, Weyemi U, Parekh PR, Huang D,
Burrell AS and Bonner WH: γH2A.X and other histone
post-translational modifications in the clinic. Biochim Biophys
Acta. 1819:743–756. 2012.PubMed/NCBI View Article : Google Scholar
|
20
|
Bligh EG and Dyer WJ: A rapid method of
total lipid extraction and purification. Can J Biochem Physiol.
3:911–917. 1959.PubMed/NCBI View
Article : Google Scholar
|
21
|
Bruzzi P, Green SB, Byar DP, Brinton LA
and Schairer C: Estimating the population attributable risk for
multiple risk factors using case-control data. Am J Epidemiol.
122:904–914. 1985.PubMed/NCBI View Article : Google Scholar
|
22
|
Lo JJ, Park YM, Sinha R and Sandler DP:
Association between meet consumption and risk of breast cancer:
Findings from the Sister Study. Int J Cancer. 146:2156–2165.
2020.PubMed/NCBI View Article : Google Scholar
|
23
|
Fiolet T, Srour B, Sellem L, Kesse-Guyot
E, Allès B, Mèjean C, Deschasaux M, Fassier P, Latino-Martel P,
Beslay M, et al: Consumption of ultra-processed foods and cancer
risk: Results from NutriNet-Sanè prospective cohort. BMJ.
360(k322)2018.PubMed/NCBI View
Article : Google Scholar
|
24
|
Chen P, Hu P, Xie D, Wang F and Wang H:
Meta-analysis of vitamin D, calcium and the prevention of breast
cancer. Breast Cancer Res Treat. 121:469–477. 2010.PubMed/NCBI View Article : Google Scholar
|
25
|
Moorehead RA: Rodent models assessing
mammary tumor prevention by soy or soy isofravones. Genes (Basel).
10(566)2019.PubMed/NCBI View Article : Google Scholar
|
26
|
Hamazaki T, Nagasawa Y, Hamazaki K and
Itomura M: Inhibitory effect of 5,8,11-eicosatorienoic acid on
angiogenesis. Prostaglandins Leukot Essent Fatty Acids. 86:221–224.
2012.PubMed/NCBI View Article : Google Scholar
|
27
|
Eynard AR, Jiang WG and Mansel RE:
Eicosatrienoic acid (20:3 n-9) inhibits the expression of
E-cadherin and desmoglein in human squamous cell carcinoma in
vitro. Prostaglandins Leukot Essent Fatty Acids. 59:371–377.
1998.PubMed/NCBI View Article : Google Scholar
|
28
|
Tsubura A, Yoshizawa K and Sasaki T:
Methylnitrosourea. In Waxler P (Ed.), Encyclopedia of Toxicology,
3rd edition. Elsevier Inc., Academic press vol. 3, pp. 321-323,
2014.
|
29
|
Watabe T, Ishizuka T, Isobe M and Ozawa N:
A 7-hydoroxymethyl sulfate ester as an active metabolite of 7,
12-dimethyl[alpha]anthracene. Science. 215:403–405. 1982.PubMed/NCBI View Article : Google Scholar
|
30
|
Lee HJ, Lee YJ, Kang CM, Bae S, Jeoung D,
Jang JJ, Lee SS, Cho CK and Lee YS: Differential gene signatures in
rat mammary tumors induced by DMBA and those induced by
tractionated gamma radiation. Radiat Res. 170:579–590.
2008.PubMed/NCBI View
Article : Google Scholar
|
31
|
Okuyama H, Kobayashi T and Watanabe S:
Dietary fatty acids-the N-6/N-3 balance and chronic elderly
diseases. Excess the linoleic acid and relative N-3 deficiency
syndrome seen in Japan. Prog Lipid Res. 35:409–457. 1996.PubMed/NCBI View Article : Google Scholar
|